Core Laboratories Inc. (CLB)

Core Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.63	19.16	15.12	15.43	17.7	13.81
Cash & Short-Term Investments	25.63	19.16	15.12	15.43	17.7	13.81
Cash Growth	19.35%	26.70%	-2.00%	-12.85%	28.23%	24.47%
Accounts Receivable	110.26	111.76	109.35	106.91	96.83	83.19
Other Receivables	14.72	15.59	13.72	8.19	9.91	9.68
Receivables	124.97	127.36	123.07	115.1	106.74	92.87
Inventory	58.24	59.4	71.7	60.45	45.44	38.15
Prepaid Expenses	10.06	10.18	8.15	15.67	14.06	14.8
Other Current Assets	8.01	10.52	5.09	5.06	5.11	6.23
Total Current Assets	226.91	226.61	223.14	211.7	189.06	165.85
Property, Plant & Equipment	152.01	153.55	153.47	157.41	172.34	181.68
Long-Term Investments	-	5.08	4.84	4.45	4.16	4.09
Goodwill	100.01	99.45	99.45	99.45	99.45	99.45
Other Intangible Assets	6.11	6.4	6.93	7.48	8.14	8.58
Long-Term Deferred Tax Assets	70.51	69.61	69.2	68.57	70.46	72.78
Other Long-Term Assets	35.81	29.71	29.38	29.3	37.26	36.16
Total Assets	591.36	590.41	586.4	578.35	580.85	568.58
Accounts Payable	36.95	34.55	33.51	45.85	29.73	23.03
Accrued Expenses	27.22	30.01	24.73	28.25	26.76	33.08
Current Portion of Leases	11.47	10.69	10.18	11.7	12.34	11.44
Current Income Taxes Payable	3.51	4.85	7.28	3.03	6.5	8.35
Current Unearned Revenue	7.26	9.33	4.76	5.94	7.77	5.46
Other Current Liabilities	9.34	8.16	7.65	8.36	7.68	8.4
Total Current Liabilities	95.74	97.59	88.1	103.14	90.78	89.75
Long-Term Debt	114.1	126.11	163.13	172.39	194.08	261.92
Long-Term Leases	41.53	43.34	42.08	38.31	49.29	56.11
Long-Term Unearned Revenue	-	-	-	0.02	0.44	0.29
Pension & Post-Retirement Benefits	-	1.72	2.27	2.68	4.09	4.36
Long-Term Deferred Tax Liabilities	10.1	13.78	12.7	22.88	24.34	20.59
Other Long-Term Liabilities	52.5	50.13	48.31	49.99	56.84	59.98
Total Liabilities	313.97	332.67	356.59	389.4	419.85	493.01
Common Stock	0.47	0.47	0.47	1.19	1.19	1.15
Additional Paid-In Capital	113.87	109.55	110.01	102.25	101.12	41.18
Retained Earnings	173.6	150.28	120.76	85.95	68.35	50.46
Treasury Stock	-10.61	-2.54	-1.45	-1.36	-4.08	-14.08
Comprehensive Income & Other	-5.98	-5.77	-4.97	-3.78	-10.13	-7.2
Total Common Equity	271.35	251.99	224.82	184.26	156.45	71.51
Minority Interest	6.04	5.75	4.99	4.7	4.55	4.06
Shareholders' Equity	277.39	257.74	229.81	188.95	161	75.57
Total Liabilities & Equity	591.36	590.41	586.4	578.35	580.85	568.58
Total Debt	167.1	180.14	215.39	222.39	255.71	329.47
Net Cash (Debt)	-141.47	-160.99	-200.27	-206.96	-238.01	-315.66
Net Cash Per Share	-2.98	-3.38	-4.21	-4.42	-5.10	-7.10
Filing Date Shares Outstanding	46.56	46.83	46.86	46.63	46.28	44.57
Total Common Shares Outstanding	46.09	46.83	46.86	46.63	46.35	44.57
Working Capital	131.17	129.02	135.04	108.57	98.27	76.1
Book Value Per Share	5.89	5.38	4.80	3.95	3.38	1.60
Tangible Book Value	165.23	146.14	118.44	77.33	48.87	-36.52
Tangible Book Value Per Share	3.59	3.12	2.53	1.66	1.05	-0.82
Land	-	10.4	10.65	10.65	11.4	11.4
Buildings	-	117.68	120.55	120.99	120.07	117.1
Machinery	-	283.3	284.23	288.12	285.95	280.78

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q